• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Okta Shares Are Trading Higher By Around 14%; Here Are 27 Stocks Moving Premarket

    12/1/22 6:16:06 AM ET
    $AREB
    $ATNX
    $AZYO
    $BDSX
    Plastic Products
    Industrials
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AREB alert in real time by email

    Gainers

    • Pacifico Acquisition Corp. (NASDAQ:PAFO) shares rose 40.9% to $7.58 in pre-market trading after dipping around 43% on Wednesday.
    • Otonomy, Inc. (NASDAQ:OTIC) rose 17.1% to $0.2101 in pre-market trading after dropping around 22% on Wednesday. Otonomy recently posted a Q3 loss of $0.18 per share.
    • Kalera Public Limited Company (NASDAQ:KAL) shares rose 14.6% to $0.1719 in pre-market trading after dropping around 17% on Wednesday. Kalera recently announced restructuring process for German subsidiary.
    • Okta, Inc. (NASDAQ:OKTA) rose 13.8% to $60.67 in pre-market trading after the company reported better-than-expected Q3 results. The company also issued Q4 and FY23 EPS and sales guidance above analyst estimates.
    • Sonim Technologies, Inc. (NASDAQ:SONM) rose 13.7% to $0.4697 in pre-market trading. Sonim Technologies announced $17 million additional tablet order.
    • American Rebel Holdings, Inc. (NASDAQ:AREB) rose 13.6% to $0.2787 in pre-market trading after dropping 15% on Wednesday. American Rebel Holdings recently posted a Q3 loss of $0.36 per share.
    • Ra Medical Systems, Inc. (NYSE:RMED) rose 11.8% to $2.74 in pre-market trading after jumping 16% on Wednesday. Ra Medical recently posted a Q3 loss of $4.36 per share.
    • Eos Energy Enterprises, Inc. (NASDAQ:EOSE) rose 10.4% to $1.17 in pre-market trading. Eos Energy recently reported worse-than-expected Q3 EPS and sales results.
    • Missfresh Limited (NASDAQ:MF) shares rose 10.4% to $1.70 in pre-market trading.
    • MEI Pharma, Inc. (NASDAQ:MEIP) rose 10.2% to $0.3750 in pre-market trading. Kyowa Kirin and MEI Pharma recently announced topline data from the Phase 2 MIRAGE study evaluating Zandelisib in patients with Indolent B-cell non-Hodgkin's Lymphoma in Japan.
    • Athenex, Inc. (NASDAQ:ATNX) rose 9.5% to $0.23 in pre-market trading after jumping around 22% on Wednesday.
    • Splunk Inc. (NASDAQ:SPLK) rose 9.2% to $84.84 in pre-market trading after the company reported better-than-expected results for its third quarter and raised FY23 sales guidance.
    • Guardforce AI Co., Limited (NASDAQ:GFAI) rose 8.3% to $0.2094 in pre-market trading.
    • Lordstown Motors Corp. (NASDAQ:RIDE) gained 6.6% to $1.77 in pre-market trading after jumping 16% on Wednesday. Lordstown Motors said its Endurance pickup truck achieved full homologation, EPA and CARB certification has been received and first customer vehicles are leaving the Foxconn EV Ohio plant for delivery.


    Don’t forget to check out our premarket coverage here .


    Losers

    • G-III Apparel Group, Ltd. (NASDAQ:GIII) fell 26.6% to $15.88 in pre-market trading after the company reported downbeat Q3 earnings and issued weak earnings forecast.
    • Panbela Therapeutics, Inc. (NASDAQ:PBLA) shares fell 26.1% to $0.10 in pre-market trading after declining over 7% on Wednesday. Panbela recentlys said first patients enrolled in Europe for ASPIRE trial studying Ivospemin (SBP-101) in combination with gemcitabine and nab-paclitaxel in patients with metastatic pancreatic ductal adenocarcinoma.
    • Winc, Inc. (NYSE:WBEV) fell 19% to $0.24 in pre-market trading. Winc recently posted a Q3 loss of $0.33 per share.
    • Biodesix, Inc. (NASDAQ:BDSX) shares fell 19% to $1.62 in pre-market trading after surging 47% on Wednesday.
    • Aziyo Biologics, Inc. (NASDAQ:AZYO) fell 16.7% to $5.75 in pre-market trading after the company reported a proposed public offering of common stock.
    • Elastic N.V. (NYSE:ESTC) fell 15.2% to $51.89 in pre-market trading after the company posted upbeat Q2 results and issued strong earnings forecast.
    • Myomo, Inc. (NYSE:MYO) shares fell 13.8% to $0.6999 in pre-market trading after gaining 33% on Wednesday. The company recently posted upbeat quarterly results.
    • Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) fell 10.3% to $0.1744 in pre-market trading after jumping 60% on Wednesday.
    • Cognition Therapeutics, Inc. (NASDAQ:CGTX) shares fell 10% to $3.16 in pre-market trading after jumping over 41% on Wednesday.
    • Credit Suisse Group AG (NYSE:CS) fell 8.2% to $3.01 in pre-market trading. The company recently said it expects to post a loss for the quarter. Shareholders last week also approved the company's capital raise plan.
    • XPeng Inc. (NYSE:XPEV) fell 8.2% to $9.92 in pre-market trading. XPeng shares jumped over 47% on Wednesday after reporting quarterly results.
    • Salesforce, Inc. (NYSE:CRM) shares fell 6.2% to $150.34 in pre-market trading after the company reported third-quarter results and announced that Bret Taylor will step down as vice chair and co-CEO.
    • Snowflake Inc. (NASDAQ:SNOW) shares fell 5.3% to $135.29 in pre-market trading after the company reported Q3 financial results and issued product revenue guidance.
    Get the next $AREB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AREB
    $ATNX
    $AZYO
    $BDSX

    CompanyDatePrice TargetRatingAnalyst
    Okta Inc.
    $OKTA
    3/19/2026$100.00Outperform
    Macquarie
    G-III Apparel Group LTD.
    $GIII
    3/13/2026$34.00 → $29.00Market Perform
    Telsey Advisory Group
    Okta Inc.
    $OKTA
    3/6/2026$97.00Market Perform → Outperform
    BMO Capital Markets
    Okta Inc.
    $OKTA
    3/3/2026$76.00Equal Weight
    Wells Fargo
    Eos Energy Enterprises Inc.
    $EOSE
    2/27/2026$20.00Buy → Neutral
    Guggenheim
    Biodesix Inc.
    $BDSX
    2/27/2026Mkt Perform → Outperform
    William Blair
    Snowflake Inc.
    $SNOW
    2/26/2026$275.00 → $282.00Buy
    Monness Crespi & Hardt
    Salesforce Inc.
    $CRM
    2/26/2026$235.00 → $225.00Outperform
    BMO Capital Markets
    More analyst ratings

    $AREB
    $ATNX
    $AZYO
    $BDSX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for FAMOTIDINE issued to ATHENEX INC

    Submission status for ATHENEX INC's drug FAMOTIDINE (SUPPL-13) with active ingredient FAMOTIDINE has changed to 'Approval' on 01/07/2022. Application Category: ANDA, Application Number: 075684, Application Classification: Labeling

    1/12/22 4:41:30 AM ET
    $ATNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for KLISYRI

    Submission status for ATHENEX INC's drug KLISYRI (ORIG-1) with active ingredient TIRBANIBULIN has changed to 'Approval' on 12/14/2020. Application Category: NDA, Application Number: 213189, Application Classification: Type 1 - New Molecular Entity

    12/20/20 4:30:55 PM ET
    $ATNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AREB
    $ATNX
    $AZYO
    $BDSX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Getz Heather C bought $13,972 worth of shares (20,000 units at $0.70), increasing direct ownership by 18% to 131,754 units (SEC Form 4)

    4 - MYOMO, INC. (0001369290) (Issuer)

    3/17/26 5:39:28 PM ET
    $MYO
    Industrial Specialties
    Health Care

    Director Kirk Thomas F bought $51,113 worth of shares (72,000 units at $0.71), increasing direct ownership by 15% to 553,857 units (SEC Form 4)

    4 - MYOMO, INC. (0001369290) (Issuer)

    3/16/26 6:08:14 PM ET
    $MYO
    Industrial Specialties
    Health Care

    Director Getz Heather C bought $50,960 worth of shares (70,000 units at $0.73), increasing direct ownership by 168% to 111,754 units (SEC Form 4)

    4 - MYOMO, INC. (0001369290) (Issuer)

    3/12/26 5:18:01 PM ET
    $MYO
    Industrial Specialties
    Health Care

    $AREB
    $ATNX
    $AZYO
    $BDSX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Kirk David Blair

    4 - Salesforce, Inc. (0001108524) (Issuer)

    3/18/26 7:52:26 PM ET
    $CRM
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Raghunathan Vivek

    4 - Snowflake Inc. (0001640147) (Issuer)

    3/18/26 7:29:11 PM ET
    $SNOW
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Ho Emily

    4 - Snowflake Inc. (0001640147) (Issuer)

    3/18/26 7:28:04 PM ET
    $SNOW
    Computer Software: Prepackaged Software
    Technology

    $AREB
    $ATNX
    $AZYO
    $BDSX
    SEC Filings

    View All

    SEC Form 6-K filed by Guardforce AI Co. Limited

    6-K - Guardforce AI Co., Ltd. (0001804469) (Filer)

    3/18/26 4:46:46 PM ET
    $GFAI
    Diversified Commercial Services
    Consumer Discretionary

    SEC Form 144 filed by Snowflake Inc.

    144 - Snowflake Inc. (0001640147) (Subject)

    3/18/26 4:25:25 PM ET
    $SNOW
    Computer Software: Prepackaged Software
    Technology

    SEC Form 144 filed by Snowflake Inc.

    144 - Snowflake Inc. (0001640147) (Subject)

    3/17/26 10:20:10 AM ET
    $SNOW
    Computer Software: Prepackaged Software
    Technology

    $AREB
    $ATNX
    $AZYO
    $BDSX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    The $308B Security Pivot: Reshaping Digital Safety for the Quantum Age

    VANCOUVER, British Columbia, March 19, 2026 (GLOBE NEWSWIRE) -- Equity-Insider.com News Commentary — Cybersecurity is hitting a massive turning point. Global spending is hitting $308 billion this year, reflecting a structural shift as companies race to lock down their AI-driven architectures[1]. It is no longer about stopping tomorrow's threats; hackers are stealing encrypted data right now, hoping to unlock it once the technology catches up[2]. This immediate cryptographic exposure is placing a high premium on firms like Quantum Secure Encryption Corp. (CSE:QSE) (OTCQB:QSEGF) (FSE: VN8), Kyndryl (NYSE:KD), Okta (NASDAQ:OKTA), Mitek Systems (NASDAQ:MITK), and Clear Secure (NYSE:YOU). The

    3/19/26 11:45:16 AM ET
    $KD
    $MITK
    $OKTA
    EDP Services
    Technology
    Computer peripheral equipment
    Computer Software: Prepackaged Software

    AMERICAN REBEL HOLIDNGS, INC. (NASDAQ: AREB; AREBW) ANNOUNCES 1-FOR-100 REVERSE STOCK SPLIT OF ITS COMMON STOCK AND PUBLICLY TRADED WARRANTS WITH ROUND LOT STOCKHOLDER PROTECTION TO BE EFFECTIVE ON MARCH 23, 2026

    Nashville, TN, March 19, 2026 (GLOBE NEWSWIRE) -- American Rebel Holdings, Inc. (NASDAQ:AREB) — America's Patriotic Brand (the "Company"), today announced that it will effect a reverse stock split of its outstanding shares of common stock, par value $0.001 per share (the "Common Stock"), and publicly traded warrants, par value $0.001 per share (the "Warrants"), at a ratio of 1-for-100, to be effective on March 23, 2026. The Company's Common Stock and Warrants are scheduled to begin trading on a reverse stock split-adjusted basis at the opening of Nasdaq on Monday, March 23, 2026. Following the reverse stock split, the Common Stock will continue to trade on Nasdaq under the symbol "AREB" w

    3/19/26 9:30:00 AM ET
    $AREB
    Plastic Products
    Industrials

    Snowflake Launches Project SnowWork, Bringing Outcome-Driven AI to Every Business User

    Project SnowWork brings agentic intelligence directly to business users' desktops to accelerate productivity and get work done faster Designed to orchestrate planning, analysis, and execution, Project SnowWork is an autonomous enterprise AI platform that helps business users accelerate everyday work Launching in research preview to a limited set of customers, Project SnowWork handles complex, multi-step tasks and delivers real, data-driven outcomes to business users Project SnowWork brings Snowflake's vision for the agentic enterprise to life, where enterprise data, intelligence, and action are connected in a governed way Snowflake (NYSE:SNOW), the AI Data Cloud company, today a

    3/18/26 9:00:00 AM ET
    $SNOW
    Computer Software: Prepackaged Software
    Technology

    $AREB
    $ATNX
    $AZYO
    $BDSX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Macquarie initiated coverage on Okta with a new price target

    Macquarie initiated coverage of Okta with a rating of Outperform and set a new price target of $100.00

    3/19/26 8:26:35 AM ET
    $OKTA
    Computer Software: Prepackaged Software
    Technology

    Telsey Advisory Group reiterated coverage on G-III Apparel with a new price target

    Telsey Advisory Group reiterated coverage of G-III Apparel with a rating of Market Perform and set a new price target of $29.00 from $34.00 previously

    3/13/26 8:22:27 AM ET
    $GIII
    Apparel
    Consumer Discretionary

    Okta upgraded by BMO Capital Markets with a new price target

    BMO Capital Markets upgraded Okta from Market Perform to Outperform and set a new price target of $97.00

    3/6/26 8:20:09 AM ET
    $OKTA
    Computer Software: Prepackaged Software
    Technology

    $AREB
    $ATNX
    $AZYO
    $BDSX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Eos Energy Enterprises Inc.

    SC 13D/A - Eos Energy Enterprises, Inc. (0001805077) (Subject)

    12/17/24 2:48:02 PM ET
    $EOSE
    Industrial Machinery/Components
    Miscellaneous

    Amendment: SEC Form SC 13G/A filed by Corbus Pharmaceuticals Holdings Inc.

    SC 13G/A - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Subject)

    11/14/24 7:48:14 PM ET
    $CRBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Corbus Pharmaceuticals Holdings Inc.

    SC 13G - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Subject)

    11/14/24 6:41:20 PM ET
    $CRBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AREB
    $ATNX
    $AZYO
    $BDSX
    Financials

    Live finance-specific insights

    View All

    G-III Apparel Group Declares Quarterly Dividend

    NEW YORK, March 13, 2026 (GLOBE NEWSWIRE) -- G-III Apparel Group, Ltd. (NASDAQ:GIII) today announced that its Board of Directors has declared a quarterly cash dividend of $0.10 per share. The dividend is payable on March 30, 2026 to stockholders of record on March 23, 2026. About G-III Apparel Group, Ltd.  G-III Apparel Group, Ltd. is a global fashion leader with expertise in design, sourcing, distribution, and marketing. The Company owns and licenses a portfolio of more than 30 preeminent brands, each differentiated by unique brand propositions, product categories, and consumer touchpoints. G-III owns ten iconic brands, including DKNY, Donna Karan, Karl Lagerfeld, and Vilebrequin, and l

    3/13/26 7:00:00 AM ET
    $GIII
    Apparel
    Consumer Discretionary

    G-III Apparel Group, Ltd. Reports Fourth Quarter and Full Year Fiscal 2026 Results; Provides Fiscal 2027 Outlook

    Net Sales of $2.96 Billion for Fiscal 2026, Down 7% Compared to Prior YearFiscal 2026 Net Sales Impacted by Lost Sales From PVH Brands of $254 Million With Key Owned Brands Up Mid-Single DigitsReported EPS of $1.51 for Fiscal 2026 Non-GAAP EPS of $2.61 for Fiscal 2026, Inclusive of a $0.30 Impact From Bad Debt Expense Related to the Saks Global Bankruptcy Year-End Cash of $407 MillionReturn of Capital to Shareholders of Over $50 Million in Fiscal 2026Initiated $25 Million Run-Rate Cost Savings Initiative NEW YORK, March 12, 2026 (GLOBE NEWSWIRE) -- G-III Apparel Group, Ltd. (NASDAQ:GIII) ("G-III" or the "Company") today reported results for the fourth quarter and full fiscal year 2026,

    3/12/26 7:00:00 AM ET
    $GIII
    Apparel
    Consumer Discretionary

    Myomo Reports Fourth Quarter and Full Year 2025 Financial and Operating Results

    Fourth quarter revenue of $11.4 million, full year revenue of $40.9 million 42% of fourth quarter revenue from recurring patient sources Record 241 authorizations and orders in the quarter Introduces 2026 revenue guidance of $43 million to $46 million as Company emphasizes recurring sources of revenue Conference call begins today at 4:30pm Eastern time Myomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three months and year ended December 31, 2025. "We delivered 2025 revenue at the midpoint of o

    3/9/26 4:06:00 PM ET
    $MYO
    Industrial Specialties
    Health Care

    $AREB
    $ATNX
    $AZYO
    $BDSX
    Leadership Updates

    Live Leadership Updates

    View All

    RESAAS Appoints Michael Dziekan as Director of Data Strategy

    VANCOUVER, BC, March 12, 2026 /CNW/ - RESAAS Services Inc. ("RESAAS") (TSXV:RSS) (OTCQB:RSASF), a leading provider of technology solutions for the real estate industry, is pleased to announce the appointment of Michael Dziekan as Director of Data Strategy. Dziekan will lead RESAAS' data strategy initiatives, focused on expanding the Company's data partnerships, enhancing its global real estate data infrastructure, driving new opportunities for data-driven products and services across the RESAAS platform.Dziekan brings extensive global experience in real estate data, analytics, a

    3/12/26 8:30:00 AM ET
    $IBM
    $SNOW
    Computer Manufacturing
    Technology
    Computer Software: Prepackaged Software

    Eos Energy Honors Outgoing Chair Russ Stidolph for Years of Leadership and Investment and Appoints Industry Veteran Joseph Nigro as Chair of the Board of Directors

    EDISON, N.J., Dec. 22, 2025 (GLOBE NEWSWIRE) -- Eos Energy Enterprises, Inc. (NASDAQ:EOSE) ("Eos" or the "Company") an American energy company and the leading innovator in designing, sourcing, manufacturing, and providing zinc-based battery energy storage systems (BESS) manufactured in the United States, today announced that Russ Stidolph, who has served as non-executive Chair since April 2018 and whose firm, AltEnergy, LLC, has been a lead investor in Eos for the past eleven years, has decided to step down from the Board of Directors, effective December 31, 2025, to focus his efforts, full time, on AltEnergy Acquisition Corp. The Board has appointed Joseph Nigro to succeed Stidolph as non

    12/22/25 4:36:01 PM ET
    $EOSE
    Industrial Machinery/Components
    Miscellaneous

    Okta Names Rob Bernshteyn and Paul Sagan to Board of Directors

    Okta, Inc. (NASDAQ:OKTA), the leading independent identity partner, today announced the appointment of Rob Bernshteyn and Paul Sagan to the Company's board of directors, effective December 19, 2025. "Rob and Paul bring a wealth of operational experience across SaaS, cybersecurity, and AI that will help drive Okta's next phase of growth," said Todd McKinnon, Okta CEO and Co-Founder. "Their expertise comes at a pivotal moment, as identity becomes the foundation for secure AI. With their leadership, we'll continue strengthening Okta's position as the neutral identity partner and accelerating our work to help customers safely adopt AI agents." "Okta has proven that identity is critical to sec

    12/19/25 4:01:00 PM ET
    $OKTA
    Computer Software: Prepackaged Software
    Technology